2023 Was a tricky 12 months to the biopharma market, with a number of providers downsizing and restructuring their workforces to stay afloat. There are signs of Restoration, as mergers and acquisitions picked up through the pharmaceutical and existence sciences field inside the latter Component of 2023 and have continued https://sites.google.com/view/bio-sites/blog